Delivery Order SPE2DB25D2204-SPE2DB25FTGQS

Award Date 6/16/25
Potential Completion Date 7/9/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 contract is for the delivery of WELIREG 40 MG TABLET 90S, with a period of performance through June 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $17,968.39 and a period of performance ending on July 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The contract has a ceiling value of $17,968.39 and an ultimate completion date of July 3, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WELIREG 40 MG TABLET 90S, a type of medication. The contract has a ceiling value of $17,968.39 and a completion date of July 29, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,968.39, is for the delivery of the pharmaceutical product "WELIREG 40 MG TABLET 90S" and is a firm fixed-price contract with a completion date of May 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $17,968.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567957715 WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a Delivery Order valued at $17,968.39, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication, with a performance period ending on June 17, 2025. The contract is a Firm Fixed Price arrangement, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,936.78, is for the delivery of WELIREG 40 MG TABLET 90S. The award has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor for this delivery order. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The firm-fixed-price contract has a ceiling value of $17,968.39 and an ultimate completion date of June 18, 2025. The award is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of Welireg 40 mg tablets. The contract has an ultimate completion date of May 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D2204
    Indefinite Delivery Contract
  • SPE2DB25D2204-SPE2DB25FTGQS
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WELIREG 40 MG TABLET 90S, a medication, with a ceiling value of $17,968.39 and a performance period ending on July 9, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract is not designated as a set-aside.

Generated 9/15/25, 9:50 AM